Harmony’s EPX-100, sharing the same mechanism as Longboard’s leading drug, positions the company well within this promising sector. Moreover, the potential market size for rare epilepsy treatments is ...
A recent study published in the Journal of Affective Disorders reveals a potential link between the presence of antibodies for the parasite Toxoplasma gondii and an increased risk of developing ...